Boehringer opens €255m biopharma plant
Boehringer Ingelheim doubles its biopharmaceutical production capacity at a stroke with the completion of a new plant at its site in Biberach, Germany; a similar expansion in Austria is also underway.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs